Search Results 1081-1090 of 19055 for Enzyme

  1. Bortezomib, Rituximab, and Dexamethasone with or without Temsirolimus in Treating Patients with Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma - Mayo Clinic

    About this study ... Bortezomib and temsirolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Bortezomib may also ...

  2. Flucytosine (oral route) - Side effects & dosage - Mayo Clinic

    Liver disease or; Weak immune system—Use with caution. May make these conditions worse. Dihydropyrimidine dehydrogenase (DPD) enzyme deficiency (rare hereditary ...

  3. Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery - Mayo Clinic

    RATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. ... No concurrent cytochrome P450 enzyme-inducing ...

  4. Norfloxacin (oral route) - Side effects & dosage - Mayo Clinic

    G6PD deficiency (an enzyme problem)—Anemia may occur while using this medicine. Myasthenia gravis (severe muscle weakness), or history of or; Tendinitis ...

  5. Mayo Clinic Researchers Identify Gene that Pushes Normal Pancreas Cells to Change Shape, a Key Step to Cancer Development

    Pancreatic cancer can occur when acinar cells — pancreatic cells that secrete digestive enzymes — morph into duct-like structures. This usually occurs after ...

  6. Inherited metabolic disorders - Doctors and departments - Mayo Clinic

    Caused by gene changes, these disorders affect the body's ability to change food into energy. They also affect how energy is used, such as for cell repair.

  7. Toxic hepatitis - Symptoms and causes - Mayo Clinic

    Inheriting certain gene changes that affect the liver enzymes that break down toxins might increase the risk of toxic hepatitis. Complications.

  8. centers-of-excellence

    Faculty William Oliver Tobin, M.B., B.Ch., B.A.O., Ph.D. Location Rochester, Minnesota Contact Tobin.Oliver@mayo.edu Clinical Profile ...

  9. Evaluation Of Efficacy Of Povetacicept In Adults With Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    * Stable angiotensin converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARBs) as per protocol specification. Key Exclusion Criteria ...

  10. New treatment pathways for patients with advanced heart failure - Mayo Clinic

    Therapy may include beta blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor plus neprilysin inhibitors (ARNIs), MRAs and sodium- ...